The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression.

[1]  Mark Payne,et al.  Health and Human Services , 2020, Congress and the Nation 2013-2016, Volume XIV: Politics and Policy in the 113th and 114th Congresses.

[2]  V. Gudnason,et al.  Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data , 2017, PloS one.

[3]  Mir Henglin,et al.  Visualization, Quantification, and Alignment of Spectral Drift in Population Scale Untargeted Metabolomics Data. , 2017, Analytical chemistry.

[4]  O. Okereke,et al.  The role of vitamin D in the prevention of late-life depression. , 2016, Journal of affective disorders.

[5]  Christine L. Taylor,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2016, Pediatric Clinical Practice Guidelines & Policies.

[6]  J. Manson,et al.  Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL). , 2016, Contemporary clinical trials.

[7]  Tamu Nolfo.  Mental Health: Culture, Race, and Ethnicity: A Supplement to Mental Health: A Report of the Surgeon General , 2015 .

[8]  C. Lynch,et al.  Branched-chain amino acids in metabolic signalling and insulin resistance , 2014, Nature Reviews Endocrinology.

[9]  M. Friedrich.  Research on psychiatric disorders targets inflammation. , 2014, JAMA.

[10]  G. Tseng,et al.  Plasma Biosignature and Brain Pathology related to Persistent Cognitive Impairment in Late-Life Depression , 2014, Molecular Psychiatry.

[11]  B. Penninx,et al.  Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484) , 2014, Molecular Psychiatry.

[12]  S. Spedding.  Vitamin D and Depression: A Systematic Review and Meta-Analysis Comparing Studies with and without Biological Flaws , 2014, Nutrients.

[13]  R. Thadhani,et al.  Vitamin D-binding protein and vitamin D in blacks and whites. , 2014, The New England journal of medicine.

[14]  M. Holick.  Bioavailability of vitamin D and its metabolites in black and white adults. , 2013, The New England journal of medicine.

[15]  Ishir Bhan,et al.  Vitamin D-binding protein and vitamin D status of black Americans and white Americans. , 2013, The New England journal of medicine.

[16]  A. Miller,et al.  The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D) , 2012, Molecular Psychiatry.

[17]  J. Manson,et al.  Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. , 2012, JAMA.

[18]  J. Manson,et al.  Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. , 2012, JAMA.

[19]  D. Viswanath,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2012, Pediatrics.

[20]  H. Critchley,et al.  A Neural Circuitry Linking Insulin Resistance to Depressed Mood , 2012, Psychosomatic medicine.

[21]  E. Palazidou.  The neurobiology of depression. , 2012, British medical bulletin.

[22]  I. Bhan,et al.  Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  J. Manson,et al.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. , 2012, Contemporary clinical trials.

[24]  J. Calviño,et al.  Insulin resistance and the metabolism of branched-chain amino acids in humans , 2011, Amino Acids.

[25]  D. Mozaffarian,et al.  Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. , 2011, Journal of the American College of Cardiology.

[26]  M. Berk,et al.  The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? , 2011, The Journal of clinical psychiatry.

[27]  O. Wolkowitz,et al.  Serum BDNF levels before treatment predict SSRI response in depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  M. Berk,et al.  Annual high-dose vitamin D3 and mental well-being: randomised controlled trial , 2011, British Journal of Psychiatry.

[29]  I. Bhan,et al.  Vitamin D–Binding Protein Modifies the Vitamin D–Bone Mineral Density Relationship , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  I. Hovatta,et al.  Oxidative stress in anxiety and comorbid disorders , 2010, Neuroscience Research.

[31]  O. Franco,et al.  Bidirectional association between depression and type 2 diabetes mellitus in women. , 2010, Archives of internal medicine.

[32]  Richard Harding,et al.  Short-form Zarit Caregiver Burden Interviews were valid in advanced conditions. , 2010, Journal of clinical epidemiology.

[33]  D. Kivlahan,et al.  The AUDIT Alcohol Consumption Questions (AUDIT-C) An Effective Brief Screening Test for Problem Drinking , 2010 .

[34]  Y. Conwell,et al.  Risks for depression onset in primary care elderly patients: potential targets for preventive interventions. , 2009, The American journal of psychiatry.

[35]  M. Fava,et al.  A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder. , 2009, The Journal of clinical psychiatry.

[36]  E. Bertone-Johnson.  Vitamin D and the occurrence of depression: causal association or circumstantial evidence? , 2009, Nutrition reviews.

[37]  M. Berk,et al.  Oxidative Stress in Psychiatric Disorders: Evidence Base and Therapeutic Implications , 2009 .

[38]  A. Silman,et al.  Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[39]  T. Strine,et al.  The Patient Health Questionnaire 8: current depressive symptoms among U.S. older adults, 2006 Behavioral Risk Factor Surveillance System. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[40]  T. Strine,et al.  The PHQ-8 as a measure of current depression in the general population. , 2009, Journal of affective disorders.

[41]  R. Robinson,et al.  Prevention of first-episode depression: progress and potential. , 2009, The British journal of psychiatry : the journal of mental science.

[42]  Carlos A Camargo,et al.  Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. , 2009, Archives of internal medicine.

[43]  J. Jolles,et al.  VDR gene variants associate with cognitive function and depressive symptoms in old age , 2009, Neurobiology of Aging.

[44]  P. Cuijpers,et al.  Stepped-care prevention of anxiety and depression in late life: a randomized controlled trial. , 2009, Archives of general psychiatry.

[45]  E. Vittinghoff,et al.  Sample size calculations for evaluating mediation , 2009, Statistics in medicine.

[46]  B. Roos,et al.  Some new food for thought: The role of vitamin D in the mental health of older adults , 2009, Current psychiatry reports.

[47]  J. Svartberg,et al.  Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial , 2008, Journal of internal medicine.

[48]  A. Hofman,et al.  Incidence and recurrence of late-life depression. , 2008, Archives of general psychiatry.

[49]  Felipe Fregni,et al.  A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. , 2008, The international journal of neuropsychopharmacology.

[50]  B. Devlin,et al.  Incomplete response in late-life depression: getting to remission , 2008, Dialogues in Clinical Neuroscience.

[51]  T. Peters,et al.  No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial , 2008, British Journal of Nutrition.

[52]  J. Manson,et al.  Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. , 2008, JAMA.

[53]  J Thomas Bigger,et al.  Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip , 2008, Circulation.

[54]  M. Fava,et al.  A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder , 2008, European Neuropsychopharmacology.

[55]  A. Beekman,et al.  Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial. , 2008, The American journal of clinical nutrition.

[56]  J. Walkup,et al.  Psychiatric rehospitalization among elderly persons in the United States. , 2008, Psychiatric services.

[57]  F. Gomez-Pinilla,et al.  Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition , 2008, Neuroscience.

[58]  Mark D. Miller,et al.  Preventing depression in later life: translation from concept to experimental design and implementation. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[59]  J. Aloia,et al.  Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. , 2008, The American journal of clinical nutrition.

[60]  P. Cuijpers,et al.  An epidemiological approach to depression prevention in old age. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[61]  J. Manson,et al.  Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. , 2008, JAMA.

[62]  A. Beekman,et al.  Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. , 2008, Archives of general psychiatry.

[63]  L. Carbone,et al.  Vitamin D and calcium dyshomoeostasis-associated heart failure , 2008, Heart.

[64]  E. Cherniack,et al.  Hypovitaminosis D: a widespread epidemic. , 2008, Geriatrics.

[65]  W. Harris,et al.  Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. , 2008, Atherosclerosis.

[66]  A. Richardson.  n-3 Fatty acids and mood: the devil is in the detail , 2008, British Journal of Nutrition.

[67]  L. Morales,et al.  Evaluating differential item functioning of the PRIME-MD mood module among impoverished black and white women in primary care. , 2008, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[68]  G. Oxenkrug.  Genetic and Hormonal Regulation of Tryptophan–Kynurenine Metabolism , 2007, Annals of the New York Academy of Sciences.

[69]  Richard N. Jones,et al.  Center for Epidemiologic Studies-Depression Scale (CES-D) item response bias found with Mantel-Haenszel method was successfully replicated using latent variable modeling. , 2007, Journal of clinical epidemiology.

[70]  L. Egede.  Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. , 2007, General hospital psychiatry.

[71]  W. Harris.  International recommendations for consumption of long-chain omega-3 fatty acids , 2007, Journal of cardiovascular medicine.

[72]  K. Su,et al.  A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. , 2007, The Journal of clinical psychiatry.

[73]  R. Weisinger,et al.  Omega 3 fatty acids and the brain: review of studies in depression. , 2007, Asia Pacific journal of clinical nutrition.

[74]  H. Bays.  Safety considerations with omega-3 fatty acid therapy. , 2007, The American journal of cardiology.

[75]  Y. Conwell,et al.  The clinical significance of subsyndromal depression in older primary care patients. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[76]  P. Lips.  Vitamin D status and nutrition in Europe and Asia , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[77]  David R. Williams,et al.  Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life. , 2007, Archives of general psychiatry.

[78]  Matthew S. Fritz,et al.  PSYCHOLOGICAL SCIENCE Research Article Required Sample Size to Detect the Mediated Effect , 2022 .

[79]  Michael Berk,et al.  Vitamin D deficiency may play a role in depression. , 2007, Medical hypotheses.

[80]  H. Sackeim,et al.  Vascular Depression: A Distinct Diagnostic Subtype? , 2006, Biological Psychiatry.

[81]  G. Alexopoulos.  The Vascular Depression Hypothesis: 10 Years Later , 2006, Biological Psychiatry.

[82]  G. Román.  Vascular Depression: An Archetypal Neuropsychiatric Disorder , 2006, Biological Psychiatry.

[83]  J. Lake,et al.  Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. , 2006, The Journal of clinical psychiatry.

[84]  Yvette I Sheline,et al.  Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[85]  T. Peters,et al.  Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. , 2006, The American journal of clinical nutrition.

[86]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[87]  N. Cook,et al.  Imputation strategies for blood pressure data nonignorably missing due to medication use , 2006, Clinical trials.

[88]  P. Cuijpers,et al.  Prevention of late-life depression in primary care: do we know where to begin? , 2006, The American journal of psychiatry.

[89]  P Royston,et al.  Evaluation of sample size and power for multi‐arm survival trials allowing for non‐uniform accrual, non‐proportional hazards, loss to follow‐up and cross‐over , 2006, Statistics in medicine.

[90]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[91]  M. Tomita,et al.  Differential Metabolomics Reveals Ophthalmic Acid as an Oxidative Stress Biomarker Indicating Hepatic Glutathione Consumption* , 2006, Journal of Biological Chemistry.

[92]  R. Duman,et al.  A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.

[93]  G. Parker,et al.  Omega-3 fatty acids and mood disorders. , 2006, The American journal of psychiatry.

[94]  R. Spitzer,et al.  Using the patient health questionnaire-9 to measure depression among racially and ethnically diverse primary care patients , 2006, Journal of General Internal Medicine.

[95]  B. Löwe,et al.  A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.

[96]  A. Remaley,et al.  The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans , 2006, Clinical endocrinology.

[97]  I. Katz,et al.  Outcomes of Minor and Subsyndromal Depression among Elderly Patients in Primary Care Settings , 2006, Annals of Internal Medicine.

[98]  S. Harris,et al.  Vitamin D and African Americans. , 2006, The Journal of nutrition.

[99]  P. Cuijpers,et al.  Opportunities for cost-effective prevention of late-life depression: an epidemiological approach. , 2006, Archives of general psychiatry.

[100]  Michael A. Kiraly,et al.  Vitamin D as a Neuroactive Substance: Review , 2006, TheScientificWorldJournal.

[101]  M. Rapaport,et al.  Classification and treatment of sub-threshold depression , 2006, Current opinion in psychiatry.

[102]  H. Pincus,et al.  A review and synthesis of studies on minor depression and other 'brand names' , 2006 .

[103]  Andrew H. Miller,et al.  Cytokines sing the blues: inflammation and the pathogenesis of depression. , 2006, Trends in immunology.

[104]  M. Holick,et al.  Vitamin D intakes by children and adults in the United States differ among ethnic groups. , 2005, The Journal of nutrition.

[105]  J. Manson,et al.  Low-Dose Aspirin in the Primary Prevention of Cancer: The Women’s Health Study: A Randomized Controlled Trial , 2005, JAMA.

[106]  J. Manson,et al.  Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial , 2005, JAMA.

[107]  C. Cooper,et al.  Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial , 2005, The Lancet.

[108]  J. Manson,et al.  A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women , 2005, The New England journal of medicine.

[109]  F. Taneli,et al.  The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[110]  J. McGrath,et al.  Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain , 2005, Journal of Chemical Neuroanatomy.

[111]  D. Mozaffarian,et al.  Interplay Between Different Polyunsaturated Fatty Acids and Risk of Coronary Heart Disease in Men , 2005, Circulation.

[112]  Steven A. Smith,et al.  Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. , 2005, Journal of chemical neuroanatomy.

[113]  M. Sowers,et al.  Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. , 2004, Diabetes care.

[114]  J. Unützer,et al.  Monitoring Depression Treatment Outcomes With the Patient Health Questionnaire-9 , 2004, Medical care.

[115]  A. Logan.  Omega-3 fatty acids and major depression: A primer for the mental health professional , 2004, Lipids in Health and Disease.

[116]  J. Laitinen,et al.  Fish consumption and depression: the Northern Finland 1966 birth cohort study. , 2004, Journal of affective disorders.

[117]  F. Gomez-Pinilla,et al.  Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. , 2004, Journal of neurotrauma.

[118]  L. Beilin,et al.  Omega-3 fatty acids and inflammation , 2004, Current atherosclerosis reports.

[119]  A. Kafatos,et al.  Depression and adipose polyunsaturated fatty acids in the survivors of the Seven Countries Study population of Crete. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[120]  Magnus Ingelman-Sundberg,et al.  Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. , 2004, The American journal of clinical nutrition.

[121]  D. Guilloteau,et al.  Serotoninergic neurotransmission is affected by n‐3 polyunsaturated fatty acids in the rat , 2004, Journal of neurochemistry.

[122]  Guilin Qiao,et al.  Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[123]  M. Berk,et al.  Dietary Omega-3 Fatty Acids and Depression in a Community Sample , 2004, Nutritional neuroscience.

[124]  J. Lönnqvist,et al.  Is low dietary intake of omega-3 fatty acids associated with depression? , 2004, The American journal of psychiatry.

[125]  Y. Nishiwaki,et al.  Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer , 2004, British Journal of Cancer.

[126]  Russell V. Lenth,et al.  Statistical Analysis With Missing Data (2nd ed.) (Book) , 2004 .

[127]  A. Logan.  Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. , 2003, Alternative medicine review : a journal of clinical therapeutic.

[128]  P. Cuijpers.  Examining the effects of prevention programs on the incidence of new cases of mental disorders: the lack of statistical power. , 2003, The American journal of psychiatry.

[129]  A. Hofman,et al.  Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. , 2003, The American journal of clinical nutrition.

[130]  J. Mortimer,et al.  3MS Normative Data for Elderly African Americans , 2003, Journal of clinical and experimental neuropsychology.

[131]  G. Hitman,et al.  Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? , 2002, QJM : monthly journal of the Association of Physicians.

[132]  A. Kafatos,et al.  Depression and adipose essential polyunsaturated fatty acids. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[133]  J. Cummings,et al.  Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[134]  R. Spitzer,et al.  The PHQ-9: A new depression diagnostic and severity measure , 2002 .

[135]  M. Schwald,et al.  Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets , 2002, Neuroscience Letters.

[136]  R. Turner,et al.  Race/ethnicity and depressive symptoms in community-dwelling young adults: a differential item functioning analysis , 2002, Psychiatry Research.

[137]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[138]  M. Cogswell,et al.  Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. , 2002, The American journal of clinical nutrition.

[139]  A. Beekman,et al.  The natural history of late-life depression: a 6-year prospective study in the community. , 2002, Archives of general psychiatry.

[140]  A. Stoll,et al.  How blind is double-blind? A study of fish oil versus placebo. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[141]  S. West,et al.  A comparison of methods to test mediation and other intervening variable effects. , 2002, Psychological methods.

[142]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. , 2002, The Journal of clinical investigation.

[143]  I. Skoog,et al.  The incidence of first-onset depression in a population followed from the age of 70 to 85 , 2001, Psychological Medicine.

[144]  D. Blazer,et al.  Toward a threshold for subthreshold depression: an analysis of correlates of depression by severity of symptoms using data from an elderly community sample. , 2001, The Gerontologist.

[145]  K. Honkalampi,et al.  Fish consumption, depression, and suicidality in a general population. , 2001, Archives of general psychiatry.

[146]  E. Vartiainen,et al.  Fish consumption and depressive symptoms in the general population in Finland. , 2001, Psychiatric services.

[147]  David Satcher,et al.  Mental Health: Culture, Race, and Ethnicity—A Supplement to Mental Health: A Report of the Surgeon General , 2001 .

[148]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.

[149]  M. Fava,et al.  DOCOSAHEXANOIC ACID AND ω-3 FATTY ACIDS IN DEPRESSION , 2000 .

[150]  J L Warren,et al.  Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.

[151]  R. Duman,et al.  Neuronal plasticity and survival in mood disorders , 2000, Biological Psychiatry.

[152]  A. Korten,et al.  The Australian National Survey of Mental Health and Well-Being. Common psychological symptoms and disablement. , 2000, The British journal of psychiatry : the journal of mental science.

[153]  N. Rothman,et al.  Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. , 2000, Journal of the National Cancer Institute.

[154]  S. Cole,et al.  Test of item-response bias in the CES-D scale. experience from the New Haven EPESE study. , 2000, Journal of clinical epidemiology.

[155]  D. Mischoulon,et al.  Docosahexanoic acid and omega-3 fatty acids in depression. , 2000, The Psychiatric clinics of North America.

[156]  J. Castelloe.  Paper 265-25 Sample Size Computations and Power Analysis with the SAS System , 2000 .

[157]  R. Spitzer,et al.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. , 1999, JAMA.

[158]  J. Glowacki,et al.  Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. , 1999, JAMA.

[159]  M. Maes,et al.  Major depression and activation of the inflammatory response system. , 1999, Advances in experimental medicine and biology.

[160]  D. Kivlahan,et al.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. , 1998, Archives of internal medicine.

[161]  J. Hibbeln.  Fish consumption and major depression , 1998, The Lancet.

[162]  M. Holick,et al.  Redefining vitamin D insufficiency , 1998, The Lancet.

[163]  L. Judd,et al.  Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment. , 1998, Journal of affective disorders.

[164]  R. Smith,et al.  Fatty acids, cytokines, and major depression. , 1998, Biological psychiatry.

[165]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[166]  Deborah Blacker,et al.  Development and Validation of a Structured Telephone Interview for Dementia Assessment (STIDA): The NIMH Genetics Initiative , 1997, Journal of geriatric psychiatry and neurology.

[167]  P. Brachet,et al.  1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor. , 1996, Brain research. Molecular brain research.

[168]  P. Brachet,et al.  1,25‐Dihydroxyvitamin D3, an inducer of glial cell line‐derived neurotrophic factor , 1996, Neuroreport.

[169]  S E Whitmore,et al.  Vitamin D deficiency in homebound elderly persons. , 1996, JAMA.

[170]  B. Hollis,et al.  Vitamin D deficiency in homebound elderly persons , 1996, JAMA.

[171]  D. Novins,et al.  Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research , 1995 .

[172]  Patricia J. Mrazek,et al.  Reducing risks for mental disorders: Frontiers for preventive intervention research. , 1994 .

[173]  H. Meltzer,et al.  Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression , 1993, Psychiatry Research.

[174]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[175]  L. George,et al.  Abbreviating the Duke Social Support Index for use in chronically ill elderly individuals. , 1993, Psychosomatics.

[176]  K. Muller,et al.  Power Calculations for General Linear Multivariate Models Including Repeated Measures Applications. , 1992, Journal of the American Statistical Association.

[177]  Sati Mazumdar,et al.  Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale , 1992, Psychiatry Research.

[178]  R. Reitan.  Trail Making Test: Manual for Administration and Scoring , 1992 .

[179]  M. Albert,et al.  Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. , 1991, The International journal of neuroscience.

[180]  D. Blazer,et al.  Alternative models of the stress buffering hypothesis , 1989, American journal of community psychology.

[181]  Gerda G. Fillenbaum,et al.  Multidimensional Functional Assessment of Older Adults: The Duke Older Americans Resources and Services Procedures , 1988 .

[182]  F. Bess,et al.  Validation of screening tools for identifying hearing-impaired elderly in primary care. , 1988, JAMA.

[183]  D. Rubin,et al.  Statistical Analysis with Missing Data. , 1989 .

[184]  E. Block,et al.  Effect of plasma membrane fluidity on serotonin transport by endothelial cells. , 1987, The American journal of physiology.

[185]  H. Chui,et al.  The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.

[186]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[187]  A. Norman,et al.  Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. , 1986, Endocrinology.

[188]  R. Ekins,et al.  Principles of free hormone measurement. , 1986, Journal of endocrinological investigation.

[189]  S. Epstein,et al.  Evidence for alteration of the vitamin D-endocrine system in blacks. , 1985, The Journal of clinical investigation.

[190]  J. Adams,et al.  INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3 , 1982, The Lancet.

[191]  G. Fillenbaum,et al.  The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. , 1981, Journal of gerontology.

[192]  L. Robins,et al.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. , 1981, Archives of general psychiatry.

[193]  G. Grodsky,et al.  Vitamin D deficiency inhibits pancreatic secretion of insulin. , 1980, Science.

[194]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[195]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .